Nature Publishing Group
Bajenaru, M. L.
. Optic nerve glioma in mice requires
gene inactivation and
, 8573–8577 (2003).
Bajenaru, M. L., Garbow, J. R., Perry, A., Hernandez, M. R.
& Gutmann, D. H. Natural history of neurofibromatosis 1-
associated optic nerve glioma in mice.
Reil y, K. M., Loisel, D. A., Bronson, R. T., McLaughlin, M. E.
& Jacks, T. Nf1;Trp53 mutant mice develop glioblastoma
with evidence of strain-specific effects.
Ridley, A. J., Paterson, H. F., Noble, M. & Land, H. Ras-
mediated cell cycle arrest is altered by nuclear
oncogenes to induce Schwann cell transformation.
, 1635–1645 (1988).
Dasgupta, B., Li, W., Perry, A., Gutmann, D. H. Glioma
formation in neurofibromatosis 1 reflects preferential
activation of K-RAS in astrocytes.
King, D., Yang, G., Thompson, M. A. & Hiebert, S. W.
Loss of neurofibromatosis-1 and p19
induce a multiple tumor phenotype.
Reilly, K. M.
. Susceptibility to astrocytoma in mice
is linked to chromosome 11
and subject to epigenetic effects.
Proc. Natl Acad. Sci.
, 13008–13013 (2004).
Kim, J. Y.
. Medulloblastoma tumorigenesis diverges
from cerebellar granule cell differentiation in patched
, 50–66 (2003).
Goodrich, L. V., Milenkovic, L., Higgins, K. M. & Scott, M. P.
Altered neural cell fates and medulloblastoma in mouse
, 1109–1113 (1997).
Singh, S. K.
. Identification of human brain tumour
, 396–401 (2004).
Singh, S. K.
. Identification of a cancer stem cell in
human brain tumors.
. in Ninth Annual Meeting of the Society
for Neuro-Oncology (ed. Bigner, D. D.) 323 (Duke Univ.
Press, Toronto, Ontario Canada, 2004).
Dasgupta, B., Yi, Y., Chen, D. Y., Weber, J. D. &
Gutmann, D. H.
Proteomic analysis reveals
hyperactivation of the mTOR pathway in NF1-associated
human and mouse brain tumors.
. Loss of patched and disruption of
granule cell development in a pre-neoplastic stage
The authors thank our Neurofibromatosis Center Group at
Washington University, especially A. Perry, J. Weber,
M. Watson and J. Garbow, as well as R. Wechsler-Reya for
critical reading of the manuscript. D.H.G. is supported by
grants from the Department of Defense, National Institute of
Neurological Disorders and Strokes, and James S. McDonnell
Foundation. J.R. is a scholar of the Child Health Research
Center of Excellence in Developmental Biology at Washington
University School of Medicine and receives additional support